| Pfizer AG - Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension |
| 38546 | | 01 | | Depo-Medrol Lidocaine 40 mg/mL | | Injektionssuspension | | H02BX01 | | Methylprednisolon, Kombinationen | | 03.02.1975 | | |
|
| Composition |
| methylprednisoloni acetas 40 mg, lidocaini hydrochloridum monohydricum 10 mg, macrogolum 3350, natrii chloridum, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, alcohol benzylicus 8.7 mg, miripirii chloridum, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 2.63 mg. |
| Packungsbestandteile |
| Suspension injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Lidocaini Hydrochloridum Monohydricum | 10 mg | | Methylprednisolone Acétate | 40 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lidocaini Hydrochloridum Monohydricum | 20 mg | | Methylprednisolone Acétate | 80 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Macrogol | 3350 | | Sodium Chlorure | | | Sodium Hydroxide | |
| |
|
|
